Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-22

Clinical Trial Update: Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT) [Phase 3]

View source ↗

Summary

Phase 3 trial update on colchicine for protection in patients undergoing percutaneous coronary intervention (COLCHICINE-PROTECT) evaluating potential protective…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Helwan University | Conditions: Coronary Artery Disease | Phase 3 | Status: UNKNOWN